Platelet count at baseline (Plt) and outcomes in patients (pts) with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S) in CALGB 80802 (Alliance) (C8) Abou-Alfa, Ghassan K. , Shi, Qian , Knox, Jennifer J. ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80802
Correlation between polymorphisms in the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer (NSCLC): An NCCTG N0026 based study. Abstract 198. Adjei, A. , Salavaggione, O. , Mandrekar, S. , Dy, G. ... - NCI TSM - - 2009 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - NCCTG-N0026
Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study. Adjei, Araba A , Salavaggione, Oreste E , Mandrekar, Sumithra J ... - - J Thorac Oncol - 2010 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - N0026
Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI). Advani, Ranjana H , Chen, Haiyan , Habermann, Thomas M ... - - Br. J. Haematol. - 2010 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Older Adult - C9793
The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy with Docetaxel in Patients with Metastatic Castrate Resistant Prostate Cancer: Results from a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance) Aggarwal, Rahul , Halabi, Susan , Kelly, William Kevin ... - - Cancer - 2013 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90401
Comparative analysis of outcomes in African American (AA) and white (W) patients (pts) with multiple myeloma (MM) treated with lenalidomide (LEN) or pomalidomide (POM) CALGB 100104 (Alliance) Ailawadhi, Sikander , McCarthy, Philip L. , Holstein, Sarah A. ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Transplant - CALGB-100104 , E4A03 , MM-002 , MM-009
Comparative Age-Based Prospective Multi-Institutional Observations from 12,367 Patients Enrolled to American College of Surgeons Oncology Group (ACOSOG Z901101) Trials (Alliance) Al-Refaie, Waddah B. , Decker, Paul A. , Ballman, Karla V. ... - - Ann. Surg. Oncol. - 2019 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Older Adult - Z901101
Attributes and Outcomes of Older Adults in Surgical Oncology Trials: Results from ACOSOG Z901101 (Alliance) Al-Refaie, Waddah B. , Decker, Paul A. , Pisters, Peter W.T. ... - SSO - Ann. Surg. Oncol. - 2015 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Older Adult - Z901101
Computed tomography densitometry and morphology of radiofrequency ablated Stage IA non-small cell lung cancer: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial Alexander, Erica S. , Xiong, Lillian , Baird, Grayson L. ... - - Journal of Vascular and Interventional Radiology - 2020 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4033
ACOSOG Z0030 Study Group: Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective ACOSOG Z0030 trial Allen, M. S. , Darling, G. E. , Decker, P. A. , Putnam, J. B. Jr ... - - J. Clin. Oncol. - 2007 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030
Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503) Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - - Lancet Respir Med - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0010
Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503) Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - AATS - - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-140503
Par-4 Down-regulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy Alvarez, James V. , Pan, Tien-chi , Ruth, Jason , Feng, Yi ... - - Cancer Cell - 2013 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - CALGB-150007
Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods An, Ming-Wen , Han, Yu , Meyers, Jeffrey P. , Bogaerts, Jan ... - - J. Clin. Oncol - 2015 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - NCCTG-N9741
Exploring the statistical and clinical impact of two interim analyses on the phase II design with option for direct assignment An, Ming-Wen , Mandrekar, Sumithra J. , Edelman, Martin J. ... - - Contemp Clin Trials - 2014 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-30203
Single nucleotide polymorphisms (SNPs) and circulating endothelial cells (CECs) as outcome predictors in recurrent glioblastoma (rGBM) patients (pts) treated with bevacizumab (BEV) and sorafenib (SOR). Anderson, S. K. , Lafky, J. M. , Carrero, X. W. , Kimlinger, T. K. ... - - J. Clin. Oncol. - 2011 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Neuro-Onc - NCCTG-N0776
Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance). Anurag, Meenakshi , Zhu, Mayanne , Huang, Chen , Vasaikar, Suhas ... - - J. Natl. Cancer Inst. - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Breast - ACOSOG-Z1031
Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy Apolo, Andrea B. , Ostrovnaya, Irina , Halabi, Susan ... - - J. Natl. Cancer Inst - 2013 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90102
External validation of prognostic models for overall survival (OS) in patients (pts) with advanced cancer (UC) treated with cisplatin-based chemotherapy. Apolo, Andrea Borghese , Philips, George , Ostrovnaya, Irina ... - - J. Clin. Oncol. - 2012 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90102
Lenalidomide (LEN) maintenance (MNTC) after high-dose melphalan and autologous stem cell transplant (ASCT) in multiple myeloma (MM): A meta-analysis (MA) of overall survival (OS) CALGB 100104 (Alliance) Attal, Michel , Palumbo, Antonio , Holstein, Sarah ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Myeloma - CALGB-100104
Treatment of older patients with de novo acute myeloid leukemia (AML) with one or more postremission chemotherapy courses: Analysis of four CALGB studies Baer, M. R. , George, S. L. , Sanford, B. L. , Stone, R. M. ... - ASCO - J. Clin. Oncol. - 2010 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Leukemia - C8525 , CALGB-10201 , CALGB-8923 , CALGB-9720
A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101 Baldwin, R. Michael , Owzar, Kouros , Zembutsu, Hitoshi ... - - Clin. Cancer Res. - 2012 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - PPP - CALGB-40101
Adjuvant chemotherapy for resected stage II and III colon cancer: Comparison of widely used two prognostic calculators Bardia, A. , Loprinzi, C. , Grothey, A. , Nelson, G. , Alberts, S. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - NCCTG-N0148
Adjuvant Chemotherapy for Resected Stage II and III Colon Cancer: Comparison of Two Widely Used Prognostic Calculators Bardia, Aditya , Loprinzi, Charles , Grothey, Axel , Nelson, Garth ... - - Semin Oncol - 2010 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - N0148
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - JAMA Oncol - 2017 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Health Outcome - CALGB-30607 , CALGB-30610 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-70501 , CALGB-70604 , CALGB-80405 , CALGB-90401
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048 Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - J. Clin. Oncol - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - N1048
Impact of therapy on genomics and transcriptomics in high-risk prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy Beltran, Himisha , Wyatt, Alexander W , Chedgy, Edmund C ... - - Clin. Cancer Res. - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90203
High-Dose Chemotherapy With Autologous Stem-Cell Support As Adjuvant Therapy in Breast Cancer: Overview of 15 Randomized Trials Berry, Donald A. , Ueno, Naoto T. , Johnson, Marcella M. ... - - J. Clin. Oncol - 2011 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Breast - INT-0163
Sequencing symptom control: Results from the Alliance N08C1 and N08CA genetics of chemotherapy neuropathy trials Beutler, A. S. , Kulkarni, A. , Kanwar, R. , Qin, R. ... - AACR - AACR 2013 Annual Meeting - 2013 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N08C1 , N08CA
Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy Beutler, Andreas S. , Kulkarni, Amit A. , Kanwar, Rahul ... - - Ann. Neurol. - 2014 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N08C1 , N08CA
Acute myeloid leukemia (AML) patients with an isolated trisomy display increased frequency of spliceosome mutations CALGB 8461 and 20202 (Alliance) Bhatnagar, Bhavana , Eisfeld, Ann-Kathrin , Mrózek, Krzysztof ... - ASH - Blood - 2017 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-20202 , CALGB-8461
Discovery of SNPs associated with chemotherapy-induced peripheral neuropathy (CIPN) using model estimated parameters as phenotypes CALGB 40502 (Alliance) Bhongsatiern, Jiraganya , Carbonetto, P. , Chua, Katherina C. ... - ASCPT - CLINICAL PHARMACOLOGY & THERAPEUTICS - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - PPP - CALGB-40502
Mutational Landscape and Clinical Outcome Associated with Different Rearrangements Involving 11q23/MLL in De Novo Acute Myeloid Leukemia (AML) CALB 8461 and 20202 (Alliance) Bill, Marius , Eisfeld Ann-Kathrin , Mrózek Krzysztof ... - ASH - Blood - 2017 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-20202 , CALGB-8461
Prognostic impact of the 2017 European Leukemianet (ELN) classification of adult patients (pts) with acute myeloid leukemia (AML) treated on Cancer and Leukemia Group B (CALGB)/Alliance protocols Bill, Marius , Mrózek, K , Kohlschmidt, J. , Nicolet, D. ... - EHA - HemaSphere - 2019 Abstract - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Leuk Corr Sci - C8461 , CALGB-20202 , CALGB-9665
A 17-gene leukemia stem cell (LSC) score in adult patients (pts) with acute myeloid leukemia (AML) reveals a distinct mutational landscape and refines current European Leukemianet (ELN) genetic risk stratification (Alliance) Bill, Marius , Nicolet, Deedra , Eisfeld, Ann-Kathrin ... - ASH - Blood - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-20202 , CALGB-8461
Mutations associated with a 17-gene leukemia stem cell score and its prognostic relevance in the context of the European LeukemiaNet classification for acute myeloid leukemia. Bill, Marius , Nicolet, Deedra , Kohlschmidt, Jessica ... - - Haematologica - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - C8621 , CALGB-8461 , C8721 , CALGB-10201 , CALGB-10502 , CALGB-10503 , CALGB-10603 , CALGB-11001 , CALGB-11002 , CALGB-19808 , CALGB-20202 , CALGB-8525 , CALGB-8821 , CALGB-8923 , CALGB-9022 , CALGB-9120 , CALGB-9222 , CALGB-9420 , CALGB-9621 , CALGB-9665 , CALGB-9720
Prognostic and biologic significance of transfer RNA-derived small RNAs(tsRNAs) expression in younger adult patients (pts) with cytogenetically normal acute myeloid leukemia (CN-AML) Bill, Marius , Veneziano, Dario , Kohlschmidt, Jessica ... - ASH - Blood - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - C8461 , C9665 , CALGB-20202
Impact of young (Y) age on efficacy and safety in advanced colorectal cancer (aCRC): A pooled analysis examining 6,286 patients (pts) from nine first-line phase III chemotherapy (CT) trials Blanke, C. D. , Bot, B. M. , Thomas, D. M. , Bleyer, A. , Kohne, C. ... - - J. Clin. Oncol. - 2010 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - NCCTG-N9741
Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials Blanke, Charles D. , Bot, Brian M. , Thomas, David M. ... - - J. Clin. Oncol - 2011 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - N9741
Meta-analyses of 22 randomized trials assessing the influence of chemotherapy in advanced/recurrent gastric cancer. Bleiberg, H. ... - ASCO - J. Clin. Oncol. - 2011 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - NCCTG-79-41-51 , NCCTG-83-41-51
Laparoscopically assisted vs open colectomy for colon cancer: a meta-analysis. Bonjer, H Jacob , Hop, Wim C J , Nelson, Heidi , Sargent, Daniel J ... - - Arch Surg - 2007 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - NCCTG-1515
Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance) Boora, Ganesh K. , Kanwar, Rahul , Kulkarni, Amit A. , Abyzov, Alexej ... - - Cancer Med - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N08C1
Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance) Boora, Ganesh K. , Kulkarni, Amit A. , Kanwar, Rahul ... - - J. Neurol. Sci. - 2015 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N08CA
Identification and resection of the clipped node decreases the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy – results from ACOSOG Z1071 (Alliance) Boughey, Judy C. , Ballman, Karla V. , Le-Petross, Huong T. ... - - Ann. Surg. - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Breast - ACOSOG-Z1071
Predictors of locoregional recurrence after neoadjuvant chemotherapy and surgery for node positive breast cancer: Results from ACOSOG Z1071 (Alliance) Boughey, Judy C. , Ballman, Karla , McCall, Linda ... - SABCS - Cancer Res. - 2017 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - ACOSOG-Z1071
Effect of the use of immediate reconstruction on the rates of bilateral mastectomy and adjuvant radiation therapy use in women with node-positive breast cancer treated with neoadjuvant chemotherapy on ACOSOG Z1071 (Alliance). Boughey, Judy C. , McCall, Linda , Haffty, Bruce , Buchholz, Tom ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - ACOSOG-Z1071
LACE-Bio: validation of prognostic role of tumour lymphocytic infiltration in resectable non small cell lung cancer Brambilla, E. , Domerg, C. , Lantuejoul, S. , Kratzke, R. ... - - J Thorac Oncol - 2012 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633
LACE-Bio: results of pooled analysis of prognostic and predictive values of histology and lymphocytic infiltration Brambilla, E. , Tsao, M. , Paris, E. , Lantuejoul, S. ... - - Ann. Oncol. - 2010 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633
Diabetes and Clinical Outcome in Patients with Metastatic Colorectal Cancer: CALGB 80405 (Alliance) Brown, Justin C. , Zhang, Sui , Ou, Fang-Shu , Venook, Alan P. ... - - JNCI Cancer Spectrum - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80405
Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance) Brown, Justin C , Zhang, Sui , Niedzwiecki, Donna , Saltz, Leonard B ... - - JNCI Cancer Spectr - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-89803
What is the added value of actual tumor measurements (TM) in predicting overall survival (OS)? The North Central Cancer Treatment Group (NCCTG) findings Campbell, M. E. , Mandrekar, S. J. , Hillman, S. L. , Goldberg, R. M. ... - ASCO - J. Clin. Oncol. - 2008 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - NCCTG-N0026 , NCCTG-N9741
Waterfall plots provide detailed information on magnitude of response to conventional chemotherapy in advanced colorectal cancer (ACRC) - lessons learned from N9741. Campbell, M. , Grothey, A. , Sargent, D. ... - - J. Clin. Oncol. - 2007 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - N9741
Impact of KRAS mutations on adjuvant carboplatin/paclitaxel in surgically resected stage IB NSCLC: CALGB 9633 Capelletti, M. , Wang, X. F. , Gu, L. , Graziano, S. L. ... - - J. Clin. Oncol. - 2010 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - CALGB-9633
Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (Alliance) clinical trials Castillo, Jorge J. , Mulkey, Flora , Geyer, Susan ... - - Am. J. Hematol. - 2016 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Leukemia - C9621 , C9710 , CALGB-10503 , CALGB-19808
Obesity Is An Adverse Prognostic Factor For Overall and Disease-Free Survival In Adult Acute Promyelocytic Leukemia But Not In Acute Myeloid Leukemia: A Pooled Analysis From Four Alliance Prospective Studies Castillo, Jorge J. , Mulkey, Flora , Geyer, Susan ... - - Blood - 2013 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Leukemia - CALGB-9621 , CALGB-9710 , CALGB-10503 , CALGB-19808
Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology Cerhan, Jane H , Anderson, S Keith , Butts, Alissa M , Porter, Alyx B ... - - Neurooncol Pract - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - N0577 , A221101 , N0874 , N107C
Association of Family History with Cancer Recurrence and Survival Among Patients with Stage III Colon Cancer Chan, Jennifer A. , Meyerhardt, Jeffrey A. , Niedzwiecki, Donna ... - - JAMA - 2008 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - C89803
Quality-adjusted time without symptoms or toxicity (Q-TWiST): analysis of cabozantinib versus sunitinib in patients with advanced renal cell carcinoma of intermediate or poor risk (Alliance A031203) Chen, RC , Feuilly, M , Meng, J , Lister, J , Marteau, F , Morris, M ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - A031203
Bayesian Variable Selection with Joint Modeling of Categorical and Survival Outcomes: An Application to Individualizing Chemotherapy Treatment in Advanced Colorectal Cancer Chen, Wei , Ghosh, Debashis , Raghunathan, Trivellore E. ... - - Biometrics - 2009 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - NCCTG-9741
Polygenic Inheritance of Paclitaxel-Induced Sensory Peripheral Neuropathy Driven by Axon Outgrowth Gene Sets in CALGB 40101 (Alliance) Chhibber, Aparna , Mefford, Joel , Stahl, Eli A. ... - - Pharmacogenomics J. - 2014 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - PPP - CALGB-40101
PD-L1 status and clinical outcomes to cabozantinib, sunitinib and everolimus in patients with metastatic clear-cell RCC treated on CABOSUN and METEOR clinical trials Choueiri, T.K. , Flaifel, A. , Xie, W. , Braun, D. , Ficial, M. ... - ESMO - Annal Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - A031203
Meta-analysis identifies variants in S1PR1 associated with microtubule targeting agent-induced sensory peripheral neuropathy CALGB 40101 and 40502 (Alliance) Chua, Katherina C. , Ho, Carol , Mushiroda, Tasei , Jiang, Chen ... - ASCPT - Clinical Pharmacology & Therapeutics - 2018 Abstract - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Breast - CALGB-40101 , CALGB-40502
Incidence of late recurrence in hormone receptor-positive or negative HER2-positive breast cancer receiving adjuvant trastuzumab: The combined analysis of the NCCTG (Alliance) N9831 and NSABP (NRG) B31 Trials Chumsri, Saranya , Li, Zhou , Serie, Daniel J. ... - SABCS - Cancer Res - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - NCCTG-N9831 , NSABP B-31
Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31 Chumsri, Saranya , Li, Zhuo , Serie, Daniel J. ... - - J. Clin. Oncol - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Breast - N9831 , NSABP B-31
Effects of Age and Immune Landscape on Outcome in HER2-positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials Chumsri, Saranya , Serie, Daniel J. , Li, Zhuo ... - - Clin. Cancer Res. - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Breast - N9831 , NSABP B-31
Association between adaptive immune signature and outcome in HER2-positive breast cancer treated with trastuzumab and lapatinib in the NCCTG-N9831 (Alliance) and NeoALTTO trials Chumsri, Saranya , Serie, Daniel , Mashadi-Hossein, Afshin ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - N9831
High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance) Chumsri, Saranya , Sperinde, Jeff , Liu, Heshan , Gligorov, Joseph ... - - Clin. Cancer Res. - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - N0337 , N98-32-52
Correlation of high p95HER2:HER2 ratio with poor outcome in two phase II clinical trials of trastuzumab-treated HER2-positive metastatic breast cancer. Chumsri, Saranya , Sperinde, Jeff , Liu, Heshan , Gligorov, Joseph ... - ASCO - J Clin Oncol - 2016 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - N0337 , N98-32-52
Combination trastuzumab and chemotherapy to induce immunity to multiple tumor antigens in patients with HER2-positive metastatic breast cancer: NCCTG (Alliance) studies N0337 and N98-32-52 Clynes, R. , Knutson, K. L. , Ballman, K. , Erskine, C. L. ... - ASCO - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - N0337 , N98-32-52
Acute Myeloid Leukemia (AML) with 9q aberrations occuring within a non-complex karyotype is highly associated with CEBPA and NPM1 mutations - A joint analysis of the German-Austrian AML Study Group (AMLSG) and Cancer and Leukemia Group B (CALGB) Corbacioglu, A. , Frohling, S. , Paschka, P. , Marcucci, G. ... - ASH - Blood - 2007 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-19808 , CALGB-8461 , CALGB-9621 , CALGB-9665
A pooled exploratory analysis of the effect of tumor size on survival benefit from adjuvant platinum-based chemotherapy (ACT) in node negative (N0) non-small cell lung cancer (NSCLC) Cuffe, S. , Ezzalfani, M. , Bourredjem, A. , Graziano, S. L. ... - Chicago MSTO - - 2010 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633
A Pooled Exploratory Analysis of the Impact of Tumor Size and KRAS Mutations on Survival Benefit from Adjuvant Platinum-Based Chemotherapy (ACT) in Node Negative (N0) Non-Small Cell Lung Cancer (NSCLC). Cuffe, S. , Graziano, S. , Bourredjem, A. , Pignon, J. P. ... - - J Thorac Oncol - 2011 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633
A Pooled Exploratory Analysis of the Effect of Tumor Size and KRAS Mutations on Survival Benefit from Adjuvant Platinum-Based Chemotherapy in Node Negative Non-Small Cell Lung Cancer Cuffe, Sinead , Bourredjem, Abderrahmane , Graziano, Stephen ... - - J Thorac Oncol - 2012 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633
Validation of EORTC Prognostic Factors for Adults with Low-Grade Glioma: a Report Utilizing Intergroup 86-72-511 Daniels, Thomas B. , Brown, Paul D. , Felten, Sara J. , Wu, Wenting ... - - Int J Radiat Oncol Biol Phys - 2011 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Neuro-Onc - NCCTG-86-72-51
Number of Lymph Nodes Harvested From a Mediastinal Lymphadenectomy Darling, Gail E. , Allen, Mark S. , Decker, Paul A. , Ballman, Karla ... - - Chest - 2011 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030
Causal modeling of CALGB/SWOG 80405 (Alliance) identifies primary (1°) side-related angiogenic drivers of metastatic colorectal cancer (mCRC) Das, R K , Furchtgott, L , Ou, F-S , Swanson, D , Hayete, B , Harms, B ... - ESMO - Ann Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80405
Bayesian machine learning on CALGB/SWOG 80405 (Alliance) and PEAK data identifies heterogeneous landscape of clinical predictors of overall survival (OS) in different populations of metastatic colorectal cancer (mCRC) Das, Rahul K , Ou, Fang-Shu , Washburn, Cecilia , Nixon, Andrew B. ... - ESMO GI - Annals of Oncology - 2019 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80405
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665 DeBoer, Rebecca , Koval, Gregory , Mulkey, Flora , Wetzler, Meir ... - - Leuk. Lymphoma - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-10001 , C9665
Impact of trial development time on accruals at CCOPs: The case of the MARVEL trial. Dilts, D. M. , Adjei, A. A. , Mandrekar, S. J. , Buckner, J. C. ... - - J. Clin. Oncol. - 2010 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - NCCTG-N0723
Sublobar Resection and Iodine-125 Brachytherapy for Stage 1 NSCLC, Initial Quality Assurance Review of ACOSOG Z-4032 Dipetrillo, T. A. , Heron, D. E. , Landreneau, R. J. , Logan, D. ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2009 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032
Clinical and Genome Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer Dolan, M. Eileen , El Charif, Omar , Wheeler, Heather E. ... - - Clin. Cancer Res. - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - PPP - CALGB-90401
Participation in cancer pharmacogenomic studies in 8,456 patients registered to Cancer and Leukemia Group B (Alliance) clinical trials Dressler, L. G. , Deal, A. M. , Watson, D. , Hollis, D. , Owzar, K. ... - - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Health Outcome - CALGB-40101 , CALGB-50303 , CALGB-80203 , CALGB-80303 , CALGB-80405 , CALGB-90401
Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance) Dressler, Lynn G. , Deal, Allison M. , Owzar, Kouros ... - - J. Natl. Cancer Inst - 2015 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Health Outcome - CALGB-40101 , CALGB-50303 , CALGB-80101 , CALGB-80203 , CALGB-80303 , CALGB-80405 , CALGB-90401
Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance) Dueck, A. C. , Singh, J. , Atherton, P. , Liu, H. , Novotny, P. ... - - Osteoporos Int - 2015 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - N02C1 , N03CC
Calibrating clinically significant effects in survival and response endpoints in cancer clinical trials. Dueck, A. , Sargent, D. , Novotny, P. , Decker, P. , Nelson, H. ... - ASCO - J. Clin. Oncol. - 2011 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - N0591
Quality of life (QOL) among patients (pts) with HER2+ breast cancer (bc) treated with adjuvant lapatinib and/or trastuzumab in the ALTTO study (BIG 2-06, Alliance N063D). Dueck, Amylou C. , Hillman, David W. , Kottschade, Lisa A. ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - N063D
Prognostic and predictive impact of NPM1/FLT3-ITD genotypes as defined by 2017 European LeukemiaNet (ELN) risk categorization from randomized patients with acute myeloid leukemia (AML) treated within the International RATIFY Study (ALLIANCE 10603) Döhner, Konstanze , Thiede, Christian , Jahn, Nikolaus ... - EHA - HemaSphere - 2019 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leukemia - CALGB-10603
Prognostic impact of NPM1/FLT3-ITD genotypes from randomized patients treated within the RATIFY/CALGB 10603 (Alliance) Study Döhner, Konstanze , Thiede, Christian , Larson, Richard A. ... - ASH - Blood - 2017 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leukemia - CALGB-10603
The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia Eisfeld, A-K , Mrózek, K , Kohlschmidt, J , Nicolet, D , Orwick, S ... - - Leukemia - 2017 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Leuk Corr Sci - CALGB-20202 , CALGB-8461 , CALGB-9665
Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - - Leukemia - 2018 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Leuk Corr Sci - C8461 , C8525 , C8821 , C9665 , CALGB-10201 , CALGB-10502 , CALGB-11001 , CALGB-11002 , CALGB-20202 , CALGB-8461 , CALGB-8923 , CALGB-9420 , CALGB-9720
NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - - Leukemia - 2018 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Leuk Corr Sci - C8525 , C8821 , C9022 , C9621 , C9720 , CALGB-10201 , CALGB-10502 , CALGB-10503 , CALGB-10603 , CALGB-19808 , CALGB-8923
Additional gene mutations refine the 2017 European Leukemianet (ELN) classification of adult patients (pts) with de novo acute myeloid leukemia (AML) aged <60 years: An analysis of Alliance studies Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - ASH - Blood - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - C8461 , CALGB-20202
Mutations in genes associated with familial predisposition to myeloid neoplasms:their frequency and associations with pretreatment characteristics in adult patients (pts) with presumably sporadic de novo acute myeloid leukemia (AML) (Alliance) Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - ASH - Blood - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - C8461 , CALGB-20202
Mutational landscape and gene-expression patterns in adult acute myeloid leukemias with monosomy 7 as a sole abnormality Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - - Cancer Res. - 2017 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Leuk Corr Sci - CALGB-10201 , CALGB-10503 , CALGB-10603 , CALGB-11002 , CALGB-19808 , CALGB-20202 , CALGB-8461 , CALGB-8525 , CALGB-9222 , CALGB-9420 , CALGB-9621
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma Ellingson, Benjamin M , Abrey, Lauren E , Nelson, Sarah J ... - - Neuro-oncology - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Neuro-Onc - N0874
Whole-genome analysis informs breast cancer response to aromatase inhibition Ellis, M. J. , Ding, L. , Shen, D. , Luo, J. Q. , Suman, V. J. ... - - Nature - 2012 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - PPP - ACOSOG-Z1031
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer Ellis, Matthew J , Lin, Li , Crowder, Robert , Tao, Yu , Hoog, Jeremy ... - - Breast Cancer Res Treat - 2010 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - ACOSOG-Z1031
Nut Consumption and Survival in Stage III Colon Cancer Patients: Results from CALGB 89803 (Alliance) Fadelu, Temidayo , Sui Zhang , Donna Niedzwiecki , Xing Ye ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-89803
Comparison of Reduced-Intensity Hematopoietic Cell Transplantation with Chemotherapy in Patients Aged 60–70 Years with Acute Myeloid Leukemia in First Remission Farag, Sherif S. , Maharry, Kati , Zhang, Mei-Jie , Pérez, Waleska S. ... - - Biol. Blood Marrow Transplant. - 2011 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Leukemia - CALGB-9720 , CALGB-10201
Causal modeling of CALGB 80405 (Alliance) identifies network drivers of metastatic colorectal cancer (CRC) Federico Innocenti , Heinz-Josef Lenz , Jeffrey Meyerhardt ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80405
ECOG score analysis as a proxy for health-related quality of life assessment in patients with poor or intermediate risk metastatic renal cell carcinoma from the CABOSUN trial (Alliance A031203) Feldman, D , Feuilly, M , Meng, J , Lister, J , Marteau, F , Morris, MJ ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - A031203
Genomic predictive biomarkers to anti-HER2 targeted therapies: a combined analysis of CALGB 40601 (Alliance) and PAMELA clinical trials Fernandez-Martinez, Aranzazu , Tanioka, Maki , Fan, Cheng ... - ASCO - J. Clin. Oncol. - 2019 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - CALGB-40601
The Impact of Adjuvant Brachytherapy with Sublobar Resection on Pulmonary Function and Dyspnea in High-risk Operable Patients; Preliminary results from the ACOSOG Z4032 Trial Fernando, Hiran C , Landreneau, Rodney J , Mandrekar, Sumithra J ... - - J Thorac Cardiovasc Surg - 2011 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032
Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030) Fibla, J. J. , Cassivi, S. D. , Decker, P. A. , Allen, M. S. ... - - J. Clin. Oncol. - 2010 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030
Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030) Fibla, Juan J. , Cassivi, Stephen D. , Decker, Paul A. ... - - Eur J Cardiothorac Surg - 2013 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030
Comparison of progression-free survival (PFS) and tumor response as endpoints for predicting overall survival (OS) in untreated extensive-stage small cell lung cancer (ED-SCLC): Findings based on North Central Cancer Treatment Group (NCCTG) trials. Foster, N. R. , Qi, Y. , Krook, J. E. , Kugler, J. W. , Kuross, S. A. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - N0424
Multitrial evaluation of progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in previously untreated extensive-stage small cell lung cancer (ES-SCLC): An Alliance-led analysis Foster, N. R. , Renfro, L. A. , Schild, S. E. , Redman, M. W. ... - - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Respiratory - Comprehensive , CALGB-9033 , CALGB-9732 , CALGB-30103 , NCCTG-862051 , NCCTG-892051 , NCCTG-932053 , ECOG-1500 , ECOG-7593 , JCOG-9511 , NCIC-BR4 , NCIC-BR8 , SWOG-S0124
Multi-Trial Evaluation of Progression-Free Survival (PFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Foster, Nathan R. , Renfro, Lindsay A. , Schild, Steven E. ... - - J Thorac Oncol - 2015 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Respiratory - CALGB-30103 , N0424 , NCCTG-932053
Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of NCCTGs phase III trials N9741 and N9841. Franko, J. , Shi, Q. , Goldman, C. D. , Pockaj, B. A. , Nelson, G. D. ... - - J. Clin. Oncol. - 2011 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - N9841 , N9741
Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841 Franko, Jan , Shi, Qian , Goldman, Charles D. , Pockaj, Barbara A. ... - - J Clin Oncol - 2012 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - N9841 , N9741
Model-based prediction of defective DNA mismatch repair using clinicopathological variables in stage II and III colon cancers. French, A. , Sinicrope, F. , Foster, N. , Thibodeau, S. , Sargent, D. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - N994C
Statistical modeling of CALGB 80405 (Alliance) to identify influential factors in metastatic colorectal cancer (CRC) dependent on primary tumor side. Furchtgott, Leon , Swanson, David , Hayete, Boris , Khalil, Iya ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80405
The Preference to Receive Chemotherapy and Cancer-related Outcomes in Older Adults with Breast Cancer CALGB 49907 (Alliance) Gajra, Ajeet , McCall, Linda , Muss, Hyman B. , Cohen, Harvey J ... - - J Geriatr Oncol - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Older Adult - CALGB-49907
Treatment-influenced associations of PML-RARalpha mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia Gallagher, R. E. , Moser, B. K. , Racevskis, J. , Poire, X. ... - - Blood - 2012 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - C9710
Clonal Markers In Relapsed Acute Promyelocytic Leukemia (APL): Clinicopathological Associations and Relation to All-Trans Retinoic Acid (ATRA) Treatment on Intergroup Phase III Trial C9710 Gallagher, R. E. , Moser, B. K. , Racevskis, J. , Poire, X. ... - - Blood - 2010 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - C9710
RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancer Gbenedio, Oghenekevwe M. , Bonnans, Caroline , Grun, Delphine ... - - JCI Insight - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80203
Cabozantinib versus sunitinib for previously untreated patients with advanced renal cell carcinoma (RCC) of intermediate or poor risk: subgroup analysis of progression-free survival (PFS) and objective response rate (ORR) in the Alliance A031203 CABOSUN trial George, Daniel , Hessel, Colin , Halabi, Susan , Sanford, Ben ... - ASCO GU - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - A031203
Central Pathology Review by Whole Slide Imaging in Glioblastoma Clinical Trials Giannini, Caterina , Miller, Ryan , Ligon, Keith , Tollefson, Helen ... - AANP - J Neuropathol Expl Neurol - 2015 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Neuro-Onc - N0872 , N0877
Analysis of prognostic (prog) Web-based models for stage II and III colon cancer (CC): A population-based validation of Numeracy (NUM) and ADJUVANT! Online (ADJ!). Gill, S. , Loprinzi, C. , Kennecke, H. , Grothey, A. , Nelson, G. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - N0148
Prognostic Web-based Models for Stage II and III Colon Cancer: a Population and Clinical Trials-based Validation of Numeracy and Adjuvant! Online Gill, Sharlene , Loprinzi, Charles , Kennecke, Hagen , Grothey, Axel ... - - Cancer - 2011 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - NCCTG-89-46-51 , NCCTG-914653
Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Germline Pharmacogenetic Studies Goetz, Matthew P. , Sun, James X. , Suman, Vera J. , Silva, Grace O. ... - - J. Natl. Cancer Inst - 2014 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - PPP - NCCTG-89-30-52
A pooled safety and efficacy analysis examining the effect of performance status (PS) on outcomes in 9 first line treatment (rx) trials (cts) of 6,286 patients (pts) with metastatic colorectal cancer (MCRC). Goldberg, R. M. , Kohne, C. H. , Seymour, M. T. , De Gramont, A. ... - - J. Clin. Oncol. - 2007 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - N0545 , N9741
Variability of Pelvic MRI Performance in a Prospective Multicenter Rectal Cancer Trial NCCTG N1048 (Alliance) Gollub, Marc J. , Shi, Qian , Nougaret, Stephanie ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - N1048
Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance) Golshan, Mehra , Cirrincione, Constance T. , Sikov, William M. ... - - Breast Cancer Res. Treat. - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Breast - CALGB-40601
Predictors of accrual success for cooperative group trials: The Cancer and Leukemia Group B (Alliance) experience Gordon, David , Liu, Qianying , Kleinman, Benjamin ... - ASCO - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Health Outcome - Comprehensive
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer (NSCLC) treated with adjuvant chemotherapy: Results from IALT, JBR.10 and ANITA Graziano, S. L. , Pignon, J. P. , Vollmer, R. T. , Kratzke, R. A. ... - IASLC (WCLC) - J Thorac Oncol - 2009 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633
LACE-Bio pooled analysis of the prognostic and predictive value of p53 mutations and expression by Immunohistochemistry (IHC) in patients with resected Non-Small Cell Lung Cancer (NSCLC). Graziano, S. , Paris, E. , Ma, X. , Pignon, J. , Hainaut, P. ... - - Ann. Oncol. - 2010 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA Graziano, Stephen L. , Lacas, Benjamin , Vollmer, Robin ... - - Lung Cancer - 2013 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633
Accuracy of FDG-PET to diagnose lung cancer in the ACOSOG Z4031 trial Grogan, E. , Deppen, S. , Ballman, K. , Andrade, G. , Verdail, F. ... - - J. Clin. Oncol. - 2012 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4031
Accuracy of FDG-PET within the clinical practice of the ACOSOG Z4031 trial to diagnose clinical stage I NSCLC Grogan, Eric L. , Deppen, Stephen A. , Ballman, Karla V. ... - - Ann. Thorac. Surg. - 2014 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4031
New lesions vs. growth of existing disease: does it impact prognosis? Grothey, A. , Heun, J. M. , Branda, M. , Goldberg, R. M. ... - ASCO - J. Clin. Oncol. - 2011 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - N9741
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer Grothey, A. , Sobrero, A.F. , Shields, A.F. , Yoshino, T. , Paul, J. ... - - N. Engl. J. Med. - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80702
Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107. Grothey, Axel , Hedrick, Eric E , Mass, Robert D , Sarkar, Somnath ... - - J. Clin. Oncol. - 2008 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - N9741
Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration Grothey, Axel , Sobrero, Alberto F. , Meyerhardt, Jeffrey A. ... - ESMO - Annals of Oncology - 2017 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - CALGB-80702
Associations of Insulin-Like Growth Factor Binding Proteins and Adiponectin with Disease Progression and Mortality in Metastatic Colorectal Cancer: Results from CALGB/SWOG 80405 (Alliance) Guercio, Brendan J. , Venook, Alan P. , Zhang, Sui , Ou, Fang-Shu ... - ASCO - J. Clin. Oncol. - 2019 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80405
Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance) Guercio, Brendan J. , Zhang, Sui , Niedzwiecki, Donna , Li, Yanping ... - - PLoS ONE - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-89803
Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405. Guercio, Brendan J , Zhang, Sui , Ou, Fang-Shu , Venook, Alan P ... - - J. Clin. Oncol. - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80405
Persistent Fatigue in Stem Cell Transplant Survivors: A Biobehavioral Perspective Hacker, Eileen Danaher , Fink, Anne , Peters, Tara , Park, Chang ... - ONS - Biol. Blood Marrow Transplant. - 2015 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - Pilot
Impact of radiation on local regional control in women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary lymph node dissection: Results from ACOSOG 1071 Clinical Trial Haffty, Bruce G. , McCall, Linda M. , Ballman, Karla V. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Breast - ACOSOG-Z1071
Radiation use and field design in women with node positive breast cancer treated with preoperative systemic therapy and breast surgery including axillary dissection on a prospective clinical trial ACOSOG Z1071 [Alliance] Haffty, Bruce G. , McCall, Linda M. , Ballman, Karla V. ... - ASTRO - Int J Radiation Biol Physics - 2015 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - ACOSOG-Z1071
Patterns of local-regional management following neoadjuvant chemotherapy in breast cancer: Results from ACOSOG Z1071 (Alliance) Haffty, Bruce G. , McCall, Linda M. , Ballman, Karla V. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Breast - ACOSOG-Z1071
Impact of radiation on local regional control in women with node positive breast cancer treated with neoadjuvant chemotherapy (NAC) and axillary lymph node dissection (ALND); results from ACOSOG Z1071 (Alliance) Haffty, Bruce , Ballman, Karla , Hunt, Kelly , McCall, Linda ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2016 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - ACOSOG-Z1071
LACE-Bio Pooled Analysis of the Prognostic and Predictive Value of TP53 mutations in Completely Resected Non Small Cell Lung Cancer (NSCLC) Hainaut, P. , Ma, X. , Lacas, B. , Tsao, M. , Douillard, J.-Y. ... - ESMO - - 2012 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633
Relationship of opioid analgesic (OA) use at 3 months and overall survival in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) Halabi, S. , Kelly, W. K. , Kaplan, E. B. ... - ASCO - J. Clin. Oncol. - 2012 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90401
A novel intermediate endpoint for predicting overall survival in men with metastatic castration-recurrent prostate cancer (CRPC) Halabi, S. , Ou, S. , Vogelzang, N. J. , Scher, H. I. ... - ASCO - J. Clin. Oncol. - 2007 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - GU - Comprehensive
Is progression free survival a predictor of overall survival in men with castration recurrent prostate cancer (CRPC)? Halabi, S. , Ou, S. , Vogelzang, N. J. ... - ASCO GU - - 2008 Abstract - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - GU - C9181 , C9182 , CALGB-90004 , CALGB-90006 , CALGB-9583 , CALGB-9680 , CALGB-9780 , CALGB-99813 , INT-0159
Use of progression-free survival (PFS) to predict overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) Halabi, S. , Rini, B. I. , Stadler, W. M. , Archer, L. E. ... - - J. Clin. Oncol. - 2010 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90206
Pain interference scores at 6-weeks from baseline and overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC) Halabi, S. , Vogelzang, N. J. , Kornblith, A. B. , Archer, L. E. ... - ASCO GU - Genitourinary Cancers Symposium - 2009 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - C9181 , C9182 , INT-0159
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer Halabi, Susan , Kelly, William Kevin , Ma, Hua , Zhou, Haojin ... - - J. Clin. Oncol - 2016 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GU - CALGB-90601
The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials. Halabi, Susan , Kelly, William Kevin , Zhou, Haojin ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - GU - CALGB-90401 , S9916
Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer Halabi, Susan , Lin, Chen-Yen , Kelly, W. Kevin , Fizazi, Karim S. ... - - J. Clin. Oncol - 2014 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90401
A prognostic model for predicting overall survival in metastatic castrate-resistant prostate cancer (mCRPC) men treated with second-line chemotherapy Halabi, Susan , Lin, Chen-Yen , Small, Eric J. ... - ASCO - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90401
Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer. Halabi, Susan , Ou, San-San , Vogelzang, Nicholas J ... - - Cancer - 2007 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - GU - C9181 , C9182 , CALGB-90004 , CALGB-90006 , CALGB-9583 , CALGB-9680 , CALGB-9780 , CALGB-99813
Progression-Free Survival (PFS) as a Surrogate Endpoint of Overall Survival (OS) in Patients with Metastatic Renal Cell Carcinoma (mRCC) Halabi, Susan , Rini, Brian , Escudier, Bernard , Stadler, Walter M. ... - - Cancer - 2014 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90206
Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer Halabi, Susan , Vogelzang, Nicholas J. , Ou, San-San , Owzar, Kouros ... - - J Clin Oncol - 2009 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GU - Comprehensive
Pain predicts overall survival in men with metastatic castration-refractory prostate cancer. Halabi, Susan , Vogelzang, Nicholas J , Kornblith, Alice B ... - - J. Clin. Oncol. - 2008 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GU - CALGB-9840 , C9181 , C9182
The impact of prior radical prostatectomy in men with metastatic castration recurrent prostate cancer: a pooled analysis of 9 Cancer and Leukemia Group B Trials. Halabi, Susan , Vogelzang, Nicholas J , Ou, San-San ... - - J. Urol. - 2007 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - GU - C9181 , C9182 , CALGB-90004 , CALGB-9000 , CALGB-9583 , CALGB-9680 , CALGB-9780 , CALGB-99813 , INT-0159
Changes in left ventricular function after radiation therapy and trastuzumab: analysis of North Central Cancer Treatment Group Phase III Trial N9831. Halyard, M. , Pisansky, T. M. , Pierce, L. J. , Solin, L. J. ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2009 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - NCCTG-N9831
Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer. Haricharan, Svasti , Punturi, Nindo , Singh, Purba ... - - Cancer Discov - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - ACOSOG-Z1031
Genome-wide profiling of archived material from CALGB 9840 and 9342 for paclitaxel (P) and trastuzumab (T) response biomarkers using gene expression and copy number analysis Harris, L. N. , Parker, J. R. , Broadwater, G. , Schulz, V. ... - - Cancer Res. - 2009 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - PPP - CALGB-9342 , CALGB-9840 , CALGB-159806
Evaluating the effect of tobacco on prostate cancer outcomes with VEGF-targeted therapy Harzstark, A. L. , Halabi, S. , Kelly, W. K. , Morris, M. J. ... - ASCO - J. Clin. Oncol. - 2012 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90401
Hypertension is associated with clinical outcome for patients (Pts) with metastatic renal cell carcinoma (RCC) treated with interferon and bevacizumab on CALGB 90206 Harzstark, A. L. , Halabi, S. , Stadler, W. M. , Vaena, D. A. ... - ASCO GU - Genitourinary Cancers Symposium - 2010 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90206
Application of 2008 WHO classification criteria for myelodysplastic syndromes (MDS) without excess blasts: Observations from Cancer and Leukemia Group B Study 10105 Hasserjian, R. , Gupta, P. , Donohue, K. A. , Owzar, K. ... - USCAP - United States and Canadian Academy of Pathology Annual Meeting - 2009 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-10105
On-treatment changes of plasma protein biomarkers in CALGB/SWOG 80405 (Alliance) Hatch, Ace J. , Ou, Fang-Shu , Zemla, Tyler , Liu , Star, Mark D. ... - ASCO GI - J. Clin. Oncol - 2019 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80405
Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance) Hatch, Ace J. , Sibley, Alexander B. , Starr, Mark D. ... - - Cancer Med - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - CALGB-80203
Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance). Hatch, Ace Joseph , Pang, Herbert , Starr, Mark D. , Brady, John C. ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80203
HER2 and response to paclitaxel in node-positive breast cancer. Hayes, Daniel F , Thor, Ann D , Dressler, Lynn G , Weaver, Donald ... - - N. Engl. J. Med. - 2007 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - CALGB-9344
Outcomes for FOLFIRI plus bevacizumab (BEV) or cetuximab (CET) in patients previously treated with oxaliplatin-based adjuvant therapy: A combined analysis of data from FIRE-3 and CALGB 80405 Heinemann, Volker , Niedzwiecki, Donna , Pearline, Rachel ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80405
Effect of socioeconomic status as measured by education level on survival in breast cancer clinical trials Herndon, J. E. , Kornblith, A. B. , Holland, J. C. ... - - Psycho-Oncology - 2013 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Disparities - C9141 , C9741 , CALGB-9082 , CALGB-9140 , CALGB-9342 , CALGB-9142 , CALGB-9343 , CALGB-9840
Patient Education Level As a Predictor of Survival In Lung Cancer Clinical Trials Herndon, James E. , Kornblith, Alice B. , Holland, Jimmie C. ... - - J Clin Oncol - 2008 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - C8931 , CALGB-8831 , C9130 , CALGB-9033 , C9532 , CALGB-9235 , CALGB-9430 , CALGB-9431 , CALGB-9534 , CALGB-9730 , CALGB-9731
Evaluation of the value of attribution in the interpretation of adverse event data: a North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigation Hillman, S. L. , Mandrekar, S. J. , Bot, B. , Dematteo, R. P. ... - - J. Clin. Oncol. - 2010 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Respiratory - ACOSOG-Z9001 , NCCTG-97-24-51
Evaluation of the Optimal Number of Lesions Needed for Tumor Evaluation Using the Response Evaluation Criteria in Solid Tumors: A North Central Cancer Treatment Group Investigation Hillman, Shauna L. , Ming-Wen, An , O'Connell, Michael J. ... - - J Clin Oncol - 2009 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - N9741
Irinotecan-induced neutropenia and UGT1A1*28: Does dose matter? Hoskins, J. M. , Goldberg, R. M. ... - - J. Clin. Oncol. - 2007 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - PPP - N9741
UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. Hoskins, Janelle M , Goldberg, Richard M , Qu, Pingping ... - - J. Natl. Cancer Inst. - 2007 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - PPP - N9741
Ki67 and PIM1 expression in aggressively treated mantle cell lymphoma (MCL): A Cancer and Leukemia Group B (CALGB) 59909 correlative science study Hsi, E. , Jung, S. , Lai, R. , Johnson, J. , Cook, J. , Jones, D. ... - - J. Clin. Oncol. - 2008 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Lymphoma - CALGB-59909
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study Hsi, Eric D. , Jung, Sin-Ho , Lai, Raymond , Johnson, Jeffrey L. ... - - Leuk. Lymphoma - 2008 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Lymphoma - CALGB-59909
Tumor markers of efficacy and resistance to cetuximab (C) treatment in metastatic colorectal cancer (mCRC): Results from CALGB 80203 (Alliance) Hurwitz, H. , Cushman, S. , Jiang, C. , Shterev, I. , Mahoney, M. R. ... - - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80203
A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials. Huschka, Mashele M , Mandrekar, Sumithra J , Schaefer, Paul L ... - - Cancer - 2007 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - N0021 , N0022 , NCCTG-95-20-53 , NCCTG-95-24-51 , NCCTG-95-24-52 , NCCTG-97-24-51 , NCCTG-98-24-52
A genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients Innocenti, F , Jiang, C , Sibley, A B , Denning, S , Etheridge, A S ... - ESMO - Ann Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - PPP - CALGB-80303
Genetic variation determines VEGF-A plasma levels in cancer patients Innocenti, Federico , Jiang, Chen , Sibley, Alexander B. ... - - Sci Rep - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - PPP - CALGB-80303
Genetic prediction of VEGF-A plasma levels in cancer patients CALGB 80303 (Alliance) Innocenti, Federico , Jiang, Chen , Sibley, Alexander ... - AACR - Cancer Res - 2016 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - PPP - CALGB-80303
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome Innocenti, Federico , Ou, Fang-Shu , Qu, Xueping , Zemla, Tyler J. ... - - J. Clin. Oncol - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - CALGB-80405
The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation Innocenti, Federico , Owzar, Kouros , Jiang, Chen , Etheridge, Amy S. ... - - PLoS ONE - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - PPP - CALGB-80303
The vitamin D receptor gene is a determinant of survival in advanced pancreatic cancer patients Innocenti, Federico , Owzar, Kouros , Jiang, Chen , Seiser, Eric ... - ECC - - 2015 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80303
A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405 Innocenti, Federico , Owzar, Kouros , Jiang, Chen ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - PPP - CALGB-80405
A Genome-Wide Association Study (GWAS) Of Survival In Metastatic Breast Cancer (MBC) Patients Treated With Letrozole (L) With Or Without Bevacizumab (B) In CALGB 40503 (Alliance) Innocenti, Federico , Owzar, Kouros , Jiang, Chen ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - PPP - CALGB-40503
Long-term Results of the Treatment of Patients With Mantle Cell Lymphoma With Cladribine (2-CDA) Alone (95-80-53) or 2-CDA and Rituximab (N0189) in the North Central Cancer Treatment Group Inwards, David J. , Fishkin, Paul A. S. , Hillman, David W. ... - - Cancer - 2008 Manuscript - Secondary-not-in-original Endpoint - Long-Term-Followup Analysis - Lymphoma - N0189 , NCCTG-95-80-53
Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis. Jaeckle, K A , Decker, P A , Ballman, K V , Flynn, P J , Giannini, C ... - - J. Neurooncol. - 2011 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Experimental - Comprehensive , NCCTG-85-72-51 , NCCTG-86-03-51 , NCCTG-88-72-02 , NCCTG-88-72-52 , NCCTG-90-72-01 , NCCTG-91-72-01 , NCCTG-92-72-03 , NCCTG-93-72-02 , NCCTG-93-72-52 , NCCTG-88-72-51 , NCCTG-89-72-51 , NCCTG-89-72-52 , NCCTG-91-72-51 , NCCTG-92-72-51 , NCCTG-93-72-51 , NCCTG-95-72-53 , NCCTG-98-72-54 , N997B , NCCTG-84-72-51 , NCCTG-86-72-02 , NCCTG-86-72-53 , N0074 , N0272 , NCCTG-98-72-52 , NCCTG-86-72-51 , NCCTG-98-72-51 , NCCTG-96-72-51
Genetic landscape of flt3-mutated acute myeloid leukemia (AML) patients treated within the ratify trial (Alliance C10603) Jahn, Nikolaus , Panina, Ekaterina , Bullinger, Lars , Dolnik, Anna ... - EHA - HemaSphere - 2019 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-10603
Comprehensive molecular profiling of FLT3-mutated acute myeloid leukemia (AML) patients treated within the RATIFY trial (Alliance) Jahn, Nikolaus , Panina, Ekaterina , Bullinger, Lars , Dolnik, Anna ... - ASH - Blood - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-10603
Prognostic and Predictive Values of KRAS in EGFR-based Subgroups and Combined with P53 in Completely Resected Non-Small Cell Lung Cancer (NSCLC): a LACE-Bio Study Janne, P. , Shepherd, F. , Domerg, C. , Le Teuff, G. , Kratzke, R. ... - - Ann. Oncol. - 2012 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633
Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance) Jansson-Knodell, Claire L. , Foster, Nathan R. , Sargent, Daniel J. ... - - J Gastrointest Oncol - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Prevention - N0147
A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Jatoi, Aminah , Burch, Patrick , Hillman, David , Vanyo, Joanne M ... - - Urology - 2007 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GU - N0351
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib Joensuu, Heikki , Eriksson, Mikael , Hall, Kirsten Sundby ... - - Cancer - 2014 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - ACOSOG-Z9001
Patients with chronic lymphocytic leukemia with high-risk genomic features have inferior outcome on successive Cancer and Leukemia Group B trials with alemtuzumab consolidation: subgroup analysis from CALGB 19901 and CALGB 10101 Jones, J. A. , Ruppert, A. S. , Zhao, W. , Lin, T. S. , Rai, K. ... - - Leuk. Lymphoma - 2013 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Leukemia - CALGB-19901 , CALGB-10101
Alemtuzumab Consolidation Does Not Improve Outcome for CLL Patients with High Risk Genomic Features on Successive CALGB Trials Jones, J. A. , Stark, A. , Zhao, W. , Lin, T. S. , Rai, K. R. ... - - Blood - 2011 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Leukemia - CALGB-10101 , CALGB-19901
Peak Oxygen Consumption and Long-Term All-Cause Mortality in Non-Small Cell Lung Cancer Jones, Lee W. , Watson, Dorothy , Herndon, James E. , Eves, Neil D. ... - - Cancer - 2010 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9238 , CALGB-140803
Standardization and documentation of surgical and pathologic variables in a multi-institutional trial of adjuvant therapy for pancreatic cancer: Results from ACOSOG Z5031 Katz, M. H. , Merchant, N. B. , Brower, S. , Campbell, M. ... - SSO - SSO Annual Meeting - 2010 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - ACOSOG-Z5031
Standardization of Surgical and Pathologic Variables is Needed in Multicenter Trials of Adjuvant Therapy for Pancreatic Cancer: Results from the ACOSOG Z5031 Trial Katz, Matthew H. G. , Merchant, Nipun B. , Brower, Steven ... - - Ann. Surg. Oncol. - 2011 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - ACOSOG-Z05031
Nomogram-Based Estimate of Axillary Nodal Involvement in ACOSOG Z0011 (Alliance): Validation and Association with Radiation Protocol Variations and Outcomes Katz, Matthew S. , McCall, Linda , Ballman, Karla , Haffty, Bruce G. ... - ASTRO - Int J Radiat Oncol Biol Phys - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - ACOSOG-Z0011
Improved outcome in recurrent glioblastoma (RGBM) patients treated with bevacizumab (BEV) and sorafenib (SOR) is predicted by a greater drop in apparent diffusion coefficient (ADC) on MRI imaging. Kaufmann, T. J. , Anderson, S. K. , Jaeckle, K. A. , Uhm, J. H. ... - SNO - 16th Annual Scientific Meeting of the Society for Neuro-Oncology in Conjunction with the AANS/CNS Section on Tumors - 2011 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Neuro-Onc - N0776
Liver metastases (LM) to predict for short overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) Kelly, W. K. , Halabi, S. , Carducci, M. A. , George, D. J. ... - ASCO - J. Clin. Oncol. - 2012 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90401
Factors impacting oncologic outcomes after sublobar pulmonary resection: Results from ACOSOG Z4032 (Alliance), a randomized trial for high-risk operable non-small cell lung cancer (NSCLC) Kent, M. , Landreneau, R. , Mandrekar, S. , Nichols, F. ... - ASCO - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032
A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032) Kent, Michael S. , Mandrekar, Sumithra J. , Landreneau, Rodney ... - - Ann. Thorac. Surg. - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032
Impact of Sublobar Resection on pulmonary function; Long-term results from Z4032 (Alliance), a randomized phase III trial Kent, Michael , Fernando, Hiran C , Mandrekar, Sumithra ... - STSA - Ann Thoracic Surg - 2016 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032
Development of a Nomogram for Predicting Outcomes after Sublobar Resection for lung cancer; An Analysis from ACOSOG Z4032 (Alliance) a Randomized Trial Kent, Michael , Mandrekar, Sumithra , Landreneau, Rodney ... - AATS - - 2015 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032
A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance) Kim, Hyung L. , Halabi, Susan , Li, Ping , Mayhew, Greg , Simko, Jeff ... - - EBioMedicine - 2015 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-150603 , CALGB-90206
A prognostic model for overall survival in patients with metastatic clear cell renal carcinoma: Results from CALGB 90206 (Alliance) Kim, Hyung L. , Halabi, Susan , Li, Ping , Mayhew, Greg , Simko, Jeff ... - AUA - J Urol - 2015 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90206
Simultaneous quantitation of abiraterone, enzalutamide, N-desmethyl enzalutamide, and bicalutamide in human plasma by LC-MS/MS Kim, Kyu-pyo , Parise, Robert A. , Holleran, Julianne L. ... - - J Pharm Biomed Anal - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - A031201
Prognostic and predictive tumor-based biomarkers in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (IFN) with or without bevacizumab (Bev): Results from CALGB (Alliance) 90206 Kluger, Harriet M. , Halabi, Susan , Solomon, Nicole C ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90206
Improved survival of HER2+ breast cancer patients treated with trastuzumab and chemotherapy is associated with host antibody immunity against the HER2 intracellular domain Knutson, Keith L. , Clynes, Raphael , Shreeder, Barath ... - - Cancer Res. - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Breast - N0337 , N98-32-52 , N0938
Associations of HER2-Specific Immunity with Survival During Treatment with Trastuzumab and Chemotherapy in Breast Cancer Knutson, Keith L. , Clynes, Raphael , Yeramian, Patrick ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - N0337 , N98-32-52 , N0938
Surgeon Error In Predicting Stage I Non-Small Cell Lung Cancer (NSCLC) Is A Major Factor Precluding Randomization In CALGB 140503 (Alliance) Kohman, Leslie J. , Gu, Lin , Altorki, Nasser , Veit, Linda J. ... - AATS - - 2016 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-140503
Validation of the International Harmonization Project (IHP) Guidelines in Early Stage Hodgkin Lymphoma (HL) Treated with Adriamycin, Vinblastine and Gemcitabine (AVG) (CALGB 50203): Early Results Kostakoglu, L. , Straus, D. J. , Schoder, H. , Lacasce, A. S. ... - ASH - ASH Annual Meeting Abstracts - 2008 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Lymphoma - CALGB-50203
Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: results from two prospective cohorts and CALGB 89803 Alliance) trial Kosumi, Keisuke , Hamada, Tsuyoshi , Zhang, Sui , Liu, Li ... - - Eur. J. Cancer - 2019 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Correl Sci NOS - CALGB-89803
Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance) Kottschade, Lisa , Novotny, Paul , Lyss, Alan , Mazurczak, Miroslaw ... - - Support Care Cancer - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N08C3
RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial N08C1 Kulkarni, Amit A. , Boora, Ganesh , Kanwar, Rahul , Ruddy, Kathryn J. ... - - Acta Oncol - 2015 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N08C1 , N08CA
FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group Kutny, M. A. , Moser, B. K. , Laumann, K. , Feusner, J. H. , Gamis, A. ... - - Pediatr Blood Cancer - 2012 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - C9710
A Comparison of Outcomes between Adolescents and Young Adults (AYA) and Children with Acute Promyelocytic Leukemia: North American Intergroup Study CALGB 9710 (Alliance) Kutny, Matthew A. , Geyer, Susan , Laumann, Kristina M ... - ASH - Blood - 2014 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leukemia - C9710
Outcome for Pediatric Acute Promyelocytic Leukemia Patients at Children’s Oncology Group Sites on the Leukemia Intergroup Study CALGB 9710 (Alliance) Kutny, Matthew A. , Geyer, Susan , Laumann, Kristina M ... - - Pediatr Blood Cancer - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Leukemia - CALGB-9710
Effect of young Age on Outcomes in Pediatric Acute Promyelocytic Leukemia: North American Intergroup Study CALGB 9710 (Alliance) Kutny, Matthew A. , Gregory, John , Geyer, Susan , Laumann, Kristina ... - ASH - Blood - 2014 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leukemia - C9710
Utility of circulating biomarkers as outcome predictors in metastatic colorectal cancer and recurrent glioblastoma multiforme patients treated with bevacizumab/sorafenib Lafky, J. M. , Anderson, S. K. , Morlan, B. W. , Nelson, G. D. ... - AACR - Cancer Res. - 2012 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - N054C
Circulating endothelial cells (CECs) in metastatic colorectal cancer (mCRC) patients treated with bevacizumab (BEV) and sorafenib Lafky, J. M. , Bot, B. M. , Morlan, B. W. , Anderson, S. K. ... - ASCO - J. Clin. Oncol. - 2011 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - N054C
Genetic variant associations with treatment outcome and safety in metastatic colorectal cancer patients treated with sorafenib and bevacizumab (BEV) as salvage therapy Lafky, J. , Bot, B. , Morlan, B. ... - AACR - Proc Am Assoc Can Res - 2011 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - N054C
Joint NABTC + NCCTG prognostic factors analysis for high grade recurrent glioma Lamborn, K. , Wu, W. , Prados, M. , Jaeckle, K. , Chang, S. ... - - J. Clin. Oncol. - 2007 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Neuro-Onc - N0678
Sensitivity of Medicare Claims Data for Measuring Use of Standard Multiagent Chemotherapy Regimens Lamont, E. B. ... - - Med Care - 2014 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - CALGB-9344 , CALGB-9730 , CALGB-9235 , CALGB-9732 , CALGB-80203 , CALGB-89803
Early relapse of follicular lymphoma after rituximab-based biologic doublet upfront therapy is associated with increased risk of death: a combined analysis from CALGB/Alliance Studies 50402, 50701 and 50803 Lansigan, Frederick , Barak, Ian , Pitcher, Brandelyn , Jung, Sin-Ho ... - ASH - Blood - 2016 Abstract - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Lymphoma - CALGB-50402 , CALGB-50701 , CALGB-50803
The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials Lansigan, Frederick , Barak, Ian , Pitcher, Brandelyn , Jung, Sin‐Ho ... - - Cancer Med - 2018 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Lymphoma - CALGB-50402 , CALGB-50701 , CALGB-50803
What Determines the Outcome for Adolescents and Young Adults With Acute Lymphoblastic Leukemia? Larson, R. A. ... - - Ann Hematol - 2008 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leukemia - C8811 , C9331 , CALGB-19802 , CALGB-8461
Psychometric Testing of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization (CI-PeriNomS) and Alliance for Clinical Trials in Oncology (Alliance) A151408 Study Data Lavoie Smith, Ellen M. , Banerjee, Tanima , Yang, James J. ... - - Cancer Nurs - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - A151408
Central review versus local review of axillary ultrasound prior to and after neoadjuvant chemotherapy: Results from the American College of Surgeons Oncology Group Z1071 trial (Alliance) Le-Petross, H. Carisa , McCall, Linda M. , Hunt, Kelly K. ... - ARRS - - 2019 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - ACOSOG-Z1071
Association Between Patient Perception of Oncology Clinical Trial Participation and Survival: NCCTG N0392 (Alliance) Le-Rademacher, Jennifer , Dueck Amylou , Chauhan, Cynthia ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - NCCTG-N0392
Association Between Patient Perception of Oncology Clinical Trial Participation and Survival: NCCTG N0392 (Alliance) Le-Rademacher, Jennifer , Dueck, Amylou , Chauhan, Cynthia ... - MASCC / ISOO - - 2016 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - NCCTG-N0392
Patient-Reported (EORTC QLQ-CIPN20) Versus Physician-Reported (CTCAE) Quantification of Oxaliplatin- and Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in NCCTG/Alliance Clinical Trials Le-Rademacher, Jennifer , Kanwar, Rahul , Seisler, Drew ... - - Support Care Cancer - 2017 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Symptom Inter - N08CA , N08CB
Validation of DPYD variants DPYD*2A, I560S, and D949V as predictors of 5-fluorouracil (5-FU)-related toxicity in stage III colon cancer (CC) patients from adjuvant trial NCCTG N0147 Lee, A. , Shi, Q. , Pavey, E. , Sargent, D. J. , Alberts, S. R. ... - - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - N0147
DPYD Variants as Predictors of 5-fluorouracil Toxicity in Adjuvant Colon Cancer Treatment (NCCTG N0147) Lee, Adam M. , Shi, Qian , Pavey, Emily , Alberts, Steven R. ... - - J. Natl. Cancer Inst - 2014 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - NCCTG-N0147
Association of micropapillary architecture and high tumor budding with prognosis in patients with stage III colon cancer from a FOLFOX-based adjuvant chemotherapy trial: NCCTG N0147 (Alliance) Lee, Hee Eun , Shi, Qian , Foster, Nate , Chan, Emily , Gill, Sharlene ... - USCAP - Mod Pathol - 2017 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - NCCTG-N0147
Impact of Consensus Molecular Subtyping (CMS) on overall survival (OS) and Progression Free Survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB / SWOG 80405 (Alliance). Lenz, Heinz-Josef , Ou, Fang-Shu , Venook, Alan P. ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - CALGB-80405
Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance). Lenz, Heinz-Josef , Ou, Fang-Shu , Venook, Alan P ... - - J. Clin. Oncol. - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - A151425 , CALGB-80405
A mentored cooperative group pilot study: atrophic vaginitis. Lester, Joanne L , Jarvis, Chandler , Bartholomew, Deborah ... - - Semin Oncol Nurs - 2014 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Onc Nursing - NCT02150525
Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics Modeling Li, CH , Bies, RR , Wang, Y , Sharma, MR , Karovic, S , Werk, L ... - - Clin Transl Sci - 2016 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - PPP - CALGB-30203 , CALGB-30303 , CALGB-9730
Identification of a Genomic Region Between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance) Li, Megan , Mulkey, Flora , Jiang, Chen , O’Neil, Bert H. ... - - Clin. Cancer Res. - 2018 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - PPP - CALGB-40502 , CALGB-80405 , CALGB-90401 , E5103
Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML Li, Z. , Huang, H. , Li, Y. , Jiang, X. , Chen, P. , Arnovitz, S. ... - - Blood - 2012 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - C9665
Activation of a Mir-181-Targeting HOXA-PBX3 Homeobox Gene Signature Is Associated with Adverse Prognosis of Cytogenetically Abnormal Acute Myeloid Leukemia Li, Z. , Huang, H. , Li, Y. , Jiang, X. , Chen, P. , Arnovitz, S. ... - ASH - ASH Annual Meeting Abstracts - 2011 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - C9665
Identification of a 24-Gene Prognostic Signature That Improves the European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: An International Collaborative Study Li, Zejuan , Herold, Tobias , He, Chunjiang , Valk, Peter J.M. ... - - J. Clin. Oncol - 2013 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Leukemia - CALGB-19808 , CALGB-9222 , CALGB-9621 , CALGB-9710 , CALGB-9720
Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840 Lichtman, S. M. , Hurria, A. , Cirrincione, C. T. , Seidman, A. D. ... - - Ann. Oncol - 2012 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Breast - CALGB-9342 , CALGB-9840
Paclitaxel in older women with breast cancer. Combined analysis of CALGB 9342 and 9840 with a focus on age Lichtman, S. M. , Hurria, A. , Cirrincione, C. T. , Seidman, A. D. ... - - Cancer Res. - 2009 Abstract - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Older Adult - CALGB-360701 , CALGB-9342 , CALGB-9840
Body mass index (BMI), tumor subtype, and relapse-free survival (RFS) in CALGB 9741 (Alliance) Ligibel, J. A. , Cirricione, C. , Liu, M. , Citron, M. , Ingle, J. ... - ASCO - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Disparities - C9741
Comparing and validating simple measures of patient-reported peripheral neuropathy (PRPN) for NCCTG Clinical Trials: A pooled analysis of 2,440 patients (pts) Liu, H. , Tan, A. D. , Grothey, A. , Schaefer, P. L. , Buckner, J. C. ... - - J. Clin. Oncol. - 2008 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N0897
Validation of Single-Item Linear Analog Scale Assessment of Quality of Life in Neuro-Oncology Patients Locke, Dona E.C. , Decker, Paul A. , Sloan, Jeff A. , Brown, Paul D. ... - - J Pain Symptom Manage - 2007 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Neuro-Onc - N0074 , NCCTG-98-72-51 , NCCTG-98-72-52
The genetic landscape of mutations in Burkitt lymphoma Love, Cassandra , Sun, Zhen , Jima, Dereje , Li, Guojie , Zhang, Jenny ... - - Nat. Genet. - 2012 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-10002
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis. Ma, Xiaoli , Le Teuff, Gwénaël , Lacas, Benjamin , Tsao, Ming Sound ... - - J Thorac Oncol - 2016 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Respiratory - CALGB-150802 , CALGB-9633
Genome-wide copy number analysis of circulating tumor cells from patients (pts) with metastatic breast cancer (MBC) Magbanua, M. M. , Sosa, E. V. , Eisenbud, L. E. , Scott, J. ... - - J. Clin. Oncol. - 2011 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - PPP - CALGB-40502
Expanded genomic profiling of circulating tumor cells in metastatic breast cancer patients to assess biomarker status and biology over time (CALGB 40502 and CALGB 40503, Alliance) Magbanua, Mark Jesus M. , Rugo, Hope S. , Wolf, Denise M. ... - - Clin. Cancer Res. - 2018 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Correl Sci NOS - CALGB-40502 , CALGB-40503
Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients Magbanua, Mark Jesus M. , Sosa, Eduardo V. , Roy, Ritu ... - - Cancer Res. - 2013 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - PPP - CALGB-40502 , CALGB-40503
Quality of life (QOL) for patients treated with FOLFOX+/-cetuximab (Cmab) following complete resection of colorectal cancer (CRC): Results from North Central Cancer Treatment Group (NCCTG) Phase III Trial N0147 Mahoney, M. R. , Sloan, J. A. , Hubbard, J. M. , Liu, H. ... - ASCO - J. Clin. Oncol. - 2011 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - N0147
Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance) Malnassy, Greg , Geyer, Susan , Fulton, Noreen , Koval, Greg ... - - Blood - 2013 Abstract - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Leuk Corr Sci - CALGB-10403 , CALGB-59909
Long‐term trajectories of self‐reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance) Mandelblatt, Jeanne S. , Clapp, Jonathan D. , Luta, Gheorghe ... - - Cancer - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Older Adult - CALGB-369901
Are actual tumor measurements or categorical tumor response status better at predicting overall survival in cancer clinical trials? Mandrekar, M. D. , Hillman, S. L. , Campbell, M. E. , Hobbs, B. ... - ASCO - J. Clin. Oncol. - 2008 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - N9741
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era Mantha, Simon , Goldman, Debra A. , Devlin, Sean M. , Lee, Ju-Whei ... - - Blood - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Leukemia - CALGB-9710
Recurring mutations found by sequencing an acute myeloid leukemia genome Mardis, E. R. , Ding, L. , Dooling, D. J. , Larson, D. E. ... - - N. Engl. J. Med. - 2009 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - C9665 , C8461
Tumor SPARC Microenvironment Signature and Plasma Levels in a Phase II Trial of Unresectable Stage IV Melanoma Treated With nab-Paclitaxel and Carboplatin: A Translational Study of NCCTG Trial N057E Markovic, S. , Suman, V. , Treiu, V. , Liu, X. , Yeh, W. , Hwang, L. ... - - J. Clin. Oncol. - 2010 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - N057E
Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082 Marks, L. B. , Cirrincione, C. , Fitzgerald, T. J. , Laurie, F. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2010 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Breast - CALGB-9082
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer Martin, M. , Prat, A. , Rodriguez-Lescure, A. , Caballero, R. ... - - Breast Cancer Res. Treat. - 2013 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Correl Sci NOS - CALGB-9342 , CALGB-9840
Evaluating the addition of bevacizumab (Bev) to endocrine therapy as first-line treatment for hormone-receptor positive (HR+)/HER2-negative advanced breast cancer (ABC): Pooled-analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials. Martin, Miguel , Loibl, Sibylle , Hyslop, Terry ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - CALGB-40503
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma Martin, Peter , Bartlett, Nancy L. , Blum, Kristie A. , Park, Steven ... - - Blood - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Lymphoma - NCT02159755
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials. Martín, M , Loibl, S , Hyslop, T , De la Haba-Rodríguez, J , Aktas, B ... - - Eur. J. Cancer - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Breast - CALGB-40503
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data Mauguen, A. , Pignon, J. P. , Burdett, S. , Domerg, C. , Fisher, D. ... - - Lancet Oncol. - 2013 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Respiratory - CALGB-8831 , CALGB-9310 , CALGB-9633 , NCCTG-892052 , NCCTG-902451 , NCCTG-942452
Elevated Pre-Treatment Serum Immunoglobulin Free Light Chains (FLC) Are Associated with Poor Event-Free and Overall Survival in Diffuse Large B-Cell Lymphoma (DLBCL) Maurer, M. J. , Micallef, I. N. , Katzmann, J. A. , Nikcevich, D. ... - ASH - ASH Annual Meeting Abstracts - 2009 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Lymphoma - NCCTG-N0489
Elevated Serum Free Light Chains Are Associated With Event-Free and Overall Survival in Two Independent Cohorts of Patients With Diffuse Large B-Cell Lymphoma Maurer, Matthew J. , Micallef, Ivana N.M. , Cerhan, James R. ... - - J Clin Oncol - 2011 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Lymphoma - N0489
CALGB/ECOG 100104 (Alliance) Study: Lenalidomide (LEN) vs Placebo (PBO) Maintenance (Maint) After Stem Cell Transplant (SCT) for Patients (Pts) With Multiple Myeloma: Overall Survival (OS) and Progression-Free Survival (PFS) Adjusted for Treatment (Tx) Crossover (XO) McCarthy, Philip L. , Holstein, Sarah A. , Jung, Sin-Ho ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Myeloma - CALGB-100104
Lenalidomide vs Placebo Maintenance After Stem Cell Transplant for Patients With Multiple Myeloma: Overall Survival and Progression-Free Survival After Adjusting for Treatment Crossover in CALGB McCarthy, Philip L. , Holstein, Sarah A. , Jung, Sin-Ho ... - EHA - Haematologica - 2017 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Myeloma - CALGB-100104
Overall and Progression-Free Survival Adjusted for Treatment Crossover in the CALGB 100104 Study of Lenalidomide Versus Placebo Maintenance After Stem Cell Transplant for Patients With Newly Diagnosed Multiple Myeloma (Alliance) McCarthy, Philip L. , Holstein, Sarah A. , Jung, Sin-Ho ... - IMW - - 2017 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Myeloma - CALGB-100104
Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis McCarthy, Philip L. , Holstein, Sarah A. , Petrucci, Maria Teresa ... - - J. Clin. Oncol - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Myeloma - CALGB-100104
Survival analysis from the CALGB trial of lenalidomide (LEN) maintenance therapy in newly diagnosed multiple myeloma (NDMM) post-autologous stem cell transplant (ASCT), adjusting for crossover (Alliance) McCarthy, Philip L. , Suman, Vera , Cooper, Miranda , Saunders, Owain ... - ASH - Blood - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Myeloma - CALGB-100104
Influence of 6q22-23 on overall survival in primary central nervous system lymphoma. Analysis of North Central Cancer Treatment Group trials 86 72 52, 93 73 51 and 96 73 51 McPhail, Ellen R. , Law, Mark E. , Decker, Paul A. ... - - Br. J. Haematol. - 2011 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - NCCTG-86-72-52 , 93-73-51 , 96-73-51
Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence Mccarter, M. D. , Antonescu, C. R. , Ballman, K. V. , Maki, R. G. ... - - J. Am. Coll. Surg. - 2012 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - ACOSOG-Z9000 , ACOSOG-Z9001
Analysis Of Overall Survival (OS) In The Context Of Cross-Over From Placebo To Lenalidomide And The Incidence Of Second Primary Malignancies (SPM) In The Phase III Study Of Lenalidomide Versus Placebo Maintenance Therapy Following Autologous Stem Cell Transplant (ASCT) For Multiple Myeloma (MM) CALGB (Alliance) ECOG BMT-CTN 100104 Mccarthy, P. , Owzar, K. , Hofmeister, C. , Richardson, P. ... - IMW - Clin Lymphoma Myeloma Leuk - 2013 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Myeloma - CALGB-100104
100% Concordance between IHC and FISH HER2 Testing Cannot Be Achieved Using N9831 Cohort Mccullough, A. E. , Chen, B. , Hillman, D. W. , Tenner, K. S. ... - USCAP - Lab Invest - 2010 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - NCCTG-N9831
Cellular transporter pharmacogenetics in metastatic colorectal cancer: Initial analysis of C80203 Mcleod, H. L. , Owzar, K. , Kroetz, D. L. , Innocenti, F. , Das, S. ... - ASCO - J. Clin. Oncol. - 2008 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - PPP - CALGB-80203
A comprehensive analysis of clinical and tumor characteristics with BRAF and KRAS mutations status in adjuvant colon cancer trial N0147. Mcwilliams, R. R. , Mahoney, M. R. , Sargent, D. J. , Nelson, G. D. ... - ASCO - J. Clin. Oncol. - 2012 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - N0147
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia Metzeler, Klaus H. , Hummel, Manuela , Bloomfield, Clara D. ... - - Blood - 2008 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Leuk Corr Sci - CALGB-8461 , CALGB-9621 , CALGB-9665
Impact of age and comorbidities on treatment effect, tolerance and toxicity in metastatic colorectal cancer (mCRC) patients treated on CALGB 80203 Meyerhardt, J. A. , Jackson, N. A. , Niedzwiecki, D. , Hollis, D. R. ... - ASCO - J. Clin. Oncol. - 2009 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80203
Ratio of metastatic to examined lymph nodes is a powerful predictor of overall survival in rectal cancer: An analysis of Intergroup 0114 Meyers, M. O. , Hollis, D. R. , Mayer, R. J. , Benson, A. B. 3rd ... - ASCO - J. Clin. Oncol. - 2007 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - C9081
Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers Miller, Christopher A. , Gindin, Yevgeniy , Lu, Charles ... - - Nat Commun - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - ACOSOG-Z1031
Development and Validation of a Dominant Clone Precision Medicine Classification for Treatment of Elderly Acute Myeloid Leukemia (Alliance) Mims, Alice S. , Borate, Uma , Kohlschmidt, Jessica , Norris, Brianna ... - ASH - Blood - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - C8461 , CALGB-20202
Comparisons between TP53 mutations and TP73 mutations in adult acute myeloid leukemia (AML) (Alliance) Mims, Alice S. , Kohlschmidt, Jessica , Eisfeld, Ann-Kathrin ... - ASH - Blood - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - C8461 , CALGB-20202
MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer Miyoshi, Jinsei , Toden, Shusuke , Yoshida, Kazuhiro , Toiyama, Yuji ... - - Sci Rep - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - N0147
Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance). Morales-Oyarvide, Vicente , Yuan, Chen , Babic, Ana , Zhang, Sui ... - - J. Natl. Cancer Inst. - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-89803
Updated results from the phase III ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T→L) or their combination (L+T) in the adjuvant treatment of HER2-positive early breast cancer Moreno-Aspitia, Alvaro , Holmes, Eileen , Jackisch, Christian ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - N063D
